Found: 12
Select item for more details and to access through your institution.
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02770-2
- By:
- Publication type:
- Article
Isolation of homozygous mutant mouse embryonic stem cells using a dual selection system.
- Published in:
- Nucleic Acids Research, 2012, v. 40, n. 3, p. e21, doi. 10.1093/nar/gkr908
- By:
- Publication type:
- Article
Agouti C57BL/6N embryonic stem cells for mouse genetic resources.
- Published in:
- Nature Methods, 2009, v. 6, n. 7, p. 493, doi. 10.1038/nmeth.1342
- By:
- Publication type:
- Article
A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies <i>Parp1</i> as a Mediator of Olaparib Toxicity.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061520
- By:
- Publication type:
- Article
Cancer‐associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 2, p. 369, doi. 10.1002/1878-0261.13537
- By:
- Publication type:
- Article
Resistance to DNA repair inhibitors in cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 21, p. 3811, doi. 10.1002/1878-0261.13224
- By:
- Publication type:
- Article
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.
- Published in:
- British Journal of Cancer, 2017, v. 117, n. 1, p. 113, doi. 10.1038/bjc.2017.133
- By:
- Publication type:
- Article
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Longitudinal analysis of a secondary BRCA2 mutation using digital droplet PCR.
- Published in:
- Journal of Pathology: Clinical Research, 2020, v. 6, n. 1, p. 3, doi. 10.1002/cjp2.146
- By:
- Publication type:
- Article
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04466-4
- By:
- Publication type:
- Article
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03917-2
- By:
- Publication type:
- Article